Regulation of autophagy by posttranslational modification of TFEB
Chinese Journal of Arteriosclerosis.2024;32(3):185-193. doi:10.20039/j.cnki.1007-3949.2024.03.001
Chinese Journal of Arteriosclerosis
2002 (v1, n1) to Present ISSN: 1671-8925
Year of publication
Sort by
Format:
Per page:
Regulation of autophagy by posttranslational modification of TFEB
Chinese Journal of Arteriosclerosis.2024;32(3):185-193. doi:10.20039/j.cnki.1007-3949.2024.03.001
Chinese Journal of Arteriosclerosis.2024;32(3):194-202. doi:10.20039/j.cnki.1007-3949.2024.03.002
Screening and validation of key genes involved in necroptosis in atherosclerosis
Chinese Journal of Arteriosclerosis.2024;32(3):203-210. doi:10.20039/j.cnki.1007-3949.2024.03.003
Association between carotid artery perivascular fat density and carotid artery steno-sis,prognosis
Chinese Journal of Arteriosclerosis.2024;32(3):211-216. doi:10.20039/j.cnki.1007-3949.2024.03.004
Chinese Journal of Arteriosclerosis.2024;32(3):217-227. doi:10.20039/j.cnki.1007-3949.2024.03.005
Chinese Journal of Arteriosclerosis.2024;32(3):228-234,270. doi:10.20039/j.cnki.1007-3949.2024.03.006
Chinese Journal of Arteriosclerosis.2024;32(3):235-242. doi:10.20039/j.cnki.1007-3949.2024.03.007
Chinese Journal of Arteriosclerosis.2024;32(3):243-248. doi:10.20039/j.cnki.1007-3949.2024.03.008
Advances in research on efferocytosis of atherosclerosis and related microRNAs
Chinese Journal of Arteriosclerosis.2024;32(3):249-256. doi:10.20039/j.cnki.1007-3949.2024.03.009
Macrophage ferroptosis and atherosclerosis
Chinese Journal of Arteriosclerosis.2024;32(3):257-262. doi:10.20039/j.cnki.1007-3949.2024.03.010
Country
China
Publisher
Editorial Office of Chinese Journal of Arteriosclerosis
ElectronicLinks
http://www.dmzzbjb.net/zgdmyhzzen/homeEditor-in-chief
JIANG Zhisheng
zgdmyhzz2022@126.com
Abbreviation
Vernacular Journal Title
中国动脉硬化杂志
ISSN
1007-3949
EISSN
Year Approved
2022
Current Indexing Status
Currently Indexed
Start Year
1993
Description
Chinese Journal of Arteriosclerosis (CN 43-1262/R, ISSN 1007-3949) is a professional academic journal governed by China Association for Science and Technology and sponsored by ChineseAssociation of Pathophysiology and University of South China. The publishing scope of the journal includes the prevention and treatment of arteriosclerotic diseases (such as hyperlipidemia, coronary artery disease, ischemic cerebrovascular disease, hypertension, arteriosclerosis and other ischemic diseases) in traditional Chinese medicine, preventive medicine, basic medicine, clinical medicine, pharmacology and special medicine. The columns include original research article (including epidemiological research, experimental research, clinical research and methodological research), review, diagnosis and treatment experience, case report, lectures, etc. The aim of the journal is to report cutting-edge theories, viewpoints, therapies and new drugs for the prevention and treatment of arteriosclerotic diseases, introduce new experience and knowledge of prevention and control, facilitate academic research and promote academic exchanges at home and abroad, and promote the improvement of human health. Since its inception, the journal has been acclaimed by authors and readers for its rigorous standard, rich content, short publication cycle and strong readability. The journal’s aimed readers are researchers engaged in arteriosclerosis, medical personnel, teachers and students in colleges and community medical working staff.Chinese Journal of Arteriosclerosis is an open access journal. All article published could be read and downloaded free of charge from this website.